Media Planner 2016

Publisher - Richard Hodson E: richard.hodson@texerepublishing.com T: +44 (0) 770 913 7760

Editorial - Stephanie Suttonstephanie.sutton@texerepublishing.com

Production - Jody Fryettjody.fryett@texerepublishing.com

Sales Manager - Helen Conyngham E: helen.conyngham@texerepublishing.comT: +44 (0) 774 705 7369

$

Editorial Vision

Celebrating the people, processes and vision that bring new drugs and biologics to marketThe development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. The Medicine Maker’s articles are practical, pragmatic and meaningful to the daily working life of all professionals in the clinical, regulatory, development and manufacturing fields. It helps them to do their jobs better. Feature articles tell the stories behind the biggest concepts, issues, challenges and advances in the field. Departments cover the ongoing developments in Technology, Business and Policy. And the Profession section offers advice on practical topics such as team management, project leadership and career development. The Medicine Maker is the publication for all professionals involved in making new medicines.

Editorial Overview

What can you expect from TMM? Case studies on successful drug development projects, expert opinions from across the globe, feature articles that explore the topic in depth, high-level business commentary, personal development for senior professionals, solutions from vendors and application specialists, and personal interviews with the leading makers of medicines.

Upfront

Reporting on the news, personalities, policies and partnerships that are shaping the development of new therapies

In My View

Experts share a single strongly-held view or key idea on drug and biologics development

Features

In-depth coverage of the most central, crucial and contentious topics in the development and manufacture of new small molecule and biologic drugs

Best Practice

The low-down from leading authorities on the techniques and methodologies that give you the results that you need

NextGen

The cutting-edge advances in research and technology that will shape drug development and manufacturing in the next five years

Profession

“News you can use” to make you and your team more effective

Sitting Down With

A one-to-one conversation with a guru of drug development

2016 Calendar

Months Editorial Themes Deadlines- Primary Packaging - Biopharmaceutical Manufacturing - Serialisation

22nd January

- Drug Delivery - Single Use Technologies - Process Control

12th February

- Hybrid System - Bioprocessing - Biosimilars & Biobetters - Cost of Analytics in Manufacturing - Special Feature: Interphex in numbers; a data driven event preview

11th March

15th April

- Bioprocess Analysis (QbD and Characterisation) - Vaccines - ADC manufacturing

13th May

- Formulation - Drug Delivery Technologies - Upstream Processing

17th June

- HP APIs - Analytical Technologies - Solid Dosage Design

15th July

12th August

- Upstream Processing - Aseptic Fill/Finish - Modulated Drug Delivery - Special Features: CPhI and ICSE in numbers; a data driven event preview

16th September

- Supply Chain Management - Continuous Bioprocessing - Emerging Markets

14th October

- Anticounterfeiting - Respiratory Drug Delivery - Bioanalysis

11th November

16th December

Bonus Distribution

DCAT

Interphex RDD

Powtech

Analytica AAPS Biotech

BioProcess International – European Summit

Controlled Release Society

CPhI Worldwide ICSE

P-MEC

Following the unprecedented response from our audience to the 2015 series our editorial team are pleased to offer these new eBook

projects for 2016:

· Industry Collaboration· Biopharma Manufacturing· Upstream Processing· Downstream Processing· Drug Delivery Innovations· Anticounterfeiting· Sustainability· Single Use Systems· API and HP API Manufacturing· Formulation Challenges· Primary Packaging· Process Control & Analytics· Aseptic Processing & Cleanrooms· Supply Chain Management

To learn how you can kick-start endless customer conversation

around your brand please contact your account representative to

discuss sponsorship opportunities.

Sponsored eBooks

January

February

March

April

May

June

July

August

September

October

November

December

Informex Pharmapack

BIO DIA

AAPS Annual Event BPI Annual Conference

Pharma Integrates CPhI and P-MEC India

- Primary Packaging - Outsourcing Trends & Challenges - API Manufacturing

- Downstream Processing - Managing Clinical Trials - Track & Trace - Special Feature: Power List - Top 100 most powerful people working in the industry

- Enhancing Manufacturing Output - Lyophilization - Corporate Social Responsibility - Special Feature: Innovation Awards

Audience & Circulation"To ensure The Medicine Maker is received by the right people (decision

makers) we have invested heavily in the development of our audience data and committed ourselves to continued quality."

Tracey Nicholls, Texere's Audience Development Manager, has over 20 year's experience in Life Science publishing. Using her industry

knowledge, she has developed a sophisticated database that allows us to build intelligent audience profiles based on the content (both print and

digital) that our readers interact with.

Print Circulation - Europe 13,250

Germany 19% UK + Ireland 18%France 15%Italy 9%Scandinavia 9%Spain 9%Switzerland 8%Benelux 6%Austria 3%Eastern Europe 2%

Portugal 1%Greece 0.5%Turkey 0.5%

Print Circulation - North America 7,000

California 35%New Jersey 11%New York 11%Pennsylvania 10%North Carolina 8%

Connecticut 5%Maryland 5%Washington DC 5%Illinois 4%New Hampshire 4%Delaware 2%

Digital Circulation - 60,150

North America 51%Europe 28%Asia 21%

Global Digital Circulation

60,150

Global Print Circulation

20,250

I am employed by:

My function is:

My primary field of work is:

45% Pharmaceutical / Biopharmaceutical

22% Contract Development and Manufacturing Organization

11% Drug Development Services

9% Clinical Research Organization (CRO)

4% Clinical Trial Organization

3% Government / Regulatory Bodies

2.5% Research Lab / Institution / Foundation

2% Data Management

1% University / Academia

0.5% Other

29% Research and Development

14% Process Development/Project Management

11% Production / Manufacturing / Engineering

9% Materials/Equipment Management

8% Management; Corporate / Marketing / Sales

8% Laboratory and Analytical Services / Management

7% Regulatory Affair

6% QA/QC, Validation

4% Clinical Affairs

4% Information Services / Management

19% Contract Services (development and manufacturing)

18% Biologic / Biopharmaceutical Development

17% Pharmaceutical m Manufacturing

15% Biological/Biopharmaceutical Manufacturing

14% Pharmaceutical Development

7% Clinical Trials

4% Discovery Research

4% Regulatory Affairs

2% Marketing and Communications

Editorial The editorial of The Medicine Maker celebrates the latest trends and breakthroughs shaping the manufacture of medicines. Readers can expect high-quality content that taps into the passions of drug development experts, with commentary, opinions, best practice tips, inspiring interviews and ‘news you can use’ to make our readers more effective in their daily jobs more effective.

Audience The Medicine Maker’s readers are some of the smartest and most influential professionals working in the global development and manufacture of new medicines. From CEOs, to Engineers, to Scientists, to Researchers, our readers are working hard to bring new drugs and biologic solutions to the market.

Products: Print, Digital, and Social

Special Issues

Magazine Advertising Newsletter & Email MarketingThe appetite for high quality, original and inspiring content remains strong. The Medicine Maker print, digital, and iPad editions are designed to create an immersive experience, providing brands with the power to influence their target customers when they are at their most open minded.

Weekly NewsletterTotal circulation: 60,150 subscribersEvery week our readers open the newsletter to engage with our content; why not leverage our loyal audience to include your marketing message?

• Newsletters get right to your company's target market. Every recipient has opted in.• We’ve built all of our newsletters to create warm leads for clients via specific products• Address topics you know will interest readers• Build frequency into your marketing campaigns - 51 issues per year delivered weekly on Friday - Intensify your marketing around major events

Advertising Options:

• Editorially led product and event profiles• White paper - Lead generating• Banner adverts

Exclusive Email Blasts:

The Medicine Maker’s email blasts allow you to deliver high value, solutions-based, educational content in a rich multimedia template. Email can be delivered to our global database of 60,150 or targeted depending on regional and segment requirements.

• Proactive and real time – communicate to a qualified audience at a time of your choosing• Target specific markets or geographical areas• Incorporate multimedia content – video, audio, animation• Generate leads• Gather market information• Captive audience – all recipients have given permission to receive email communication from The Medicine Maker

• The Power List (April)

• CPhI in Numbers. A data driven

preview (September)

• The Innovation Awards (December)

Power List2015

Content marketing continues to play an increasing role in scientific marketing: however striking a balance between engaging thought leadership and commercial messaging is vitally important.

An article or series of articles commissioned by your company and The Medicine Maker. The article(s) will be on a topic of your choosing and The Medicine Maker will help create a narrative that is suited to generating the best audience reaction.

The Medicine Maker’s Editor will project manage the campaign, taking discussions from concept to reality and providing a single point of contact throughout production.

What does each article include?

• Published in print, iPad and digital editions of The Medicine Maker• Hosted on The Medicine Maker website indefinitely• Digital marketing campaign promoting the editorial via our online portfolio• Social media awareness – Twitter and Linkedin

Collaborative Content Marketing Webinars

Webinars have become one of the most effective marketing tools for lead generation and data capture.

Benefits of conducting a webinar: • Position your company as thought leaders • Reach a large audience in diverse locations • Build faster and deeper relationships through interaction • Eliminate travel costs• Capture valuable sales leads • Extends the event's lifespan with on-demand version• Gain potential customers attention for 60 minutes

The webinar opportunities we offer:

• Educational webinars – sponsorship• Audio with power point slides (live or pre-recorded)• Video webinar (pre-recorded)• Real time product demo (pre-recorded)• Collaborative video webinar (pre-recorded)

Every webinar programs include:

• Exposure to The Medicine Maker’s audience – some of the smartest and most influential engineers and scientists working in global pharmaceutical/ biopharmaceutical development and manufacture• Pre-webinar consultation and project management• Intensive marketing program across digital, print and social channels• Fully managed creation and execution of webinar presentation • Full report with polling results and registrants' information• Indefinite on-demand hosting on The Medicine Maker website

“90% of readers f ind custom content useful and 78% believe that companies providing custom content are

interested in building good relationships” Source: McMurrary/TMG

"70% of consumers prefer getting to know a company via articles"

Source: Content Marketing Institute (CMI)

"78% of chief marketing officers think custom media represents the future of marketing."

Source: Content Marketing Institute (CMI)

Rates Summary

Magazine

Website $ DOLLARContent Wrap around $ 3,230

White Papers $ DOLLAR1 month $1,7183 Months $1,6496 Months $1,58112 Months $1,511

Content Marketing Channels $ DOLLARTMM Website Content Hub (Includes marketing package)

$ 33,350

E-Books From $20,010 -

$53,360

Preferred Positions $ DOLLAROutside Back Cover $ 1334Inside Front Cover $ 1071First Right Hand Page $ 979Preferred Position $ 783

Bellyband $ 10,877Cover Tip $ 10,877

Collaborative Content $ DOLLARCollaborative Content (2 page feature) $ 20,010

Website Whitepapers

$ DOLLAR 1 Issue 3 Issues 6 Issues 12 Issues

Product Profiles $ 1,417 $ 1,275 $ 1,205 $ 1,063Leaderboard $ 1,640 $ 1,476 $ 1,394 $ 1,230Footer banner $ 1,285 $ 1,157 $ 1,093 $ 964Road Block (Leaderboard, Footer, App note and Product)

$ 7,557 $ 7,282 $ 7,007 $ 6,733

$ DOLLAR Data Only Report and Data

5 Questions $ 5,336 $ 8,00410 Questions $ 8,004 $ 11,33915 Questions $ 11,339 $ 14,67420 Questions $ 14,674 $ 18,676

25 Questions $ 18,676 $ 24,012

Webinars $ DOLLAREducational webinar sponsorship $ 16,008Audio with Slides (Live or Pre-recorded) $ 18,676Video Webinar (Pre-recorded) $ 24,012Post Webinar Review and Promotional Package 12 months

$ 6,670

Video Projects $ DOLLARTalking Head Video $ 9,338Product demo with editorial support $ 13,340Multi angle interview style $ 13,340

Newsletters

Webinar Programs

Magazine rates 2016 $ DOLLAR

Adverts 1x 3x 6x 9x 12x 18x 24x

Full Page $ 8347 $ 8097 $ 7847 $ 7596 $ 7346 $ 7095 $ 6844

2/3 Page $ 7262 $ 7044 $6828 $ 6608 $6390 $6173 $ 5954

1/2 Page $ 6427 $ 6235 $ 6042 $ 5848 $ 5656 $ 5463 $ 5271

1/3 Page $ 4841 $ 4696 $ 4551 $ 4405 $ 4260 $ 4113 $ 3970

1/4 Page $ 4174 $ 4048 $ 3923 $ 3798 $ 3673 $ 3547 $ 3423

Weekly E-newsletter

Sponsored Survey Including Marketing

Email: richard.hodson@texerepublishing.comWebsite: www.themedicinemaker.com